Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation

Journal of the American College of Cardiology

Volumn 60, Issue 5, 2012, Pages 408-420

  Klem, Igor ^a   Weinsaft, Jonathan W ^a   Bahnson, Tristram D ^a   Hegland, Don ^a   Kim, Han W ^a   Hayes, Brenda ^a   Parker, Michele A ^a   Judd, Robert M ^a   Kim, Raymond J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiovascular magnetic resonance; implantable cardioverter defibrillator; myocardial scarring

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DEFIBRILLATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL SCARRING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCAR FORMATION; SUDDEN DEATH;

ADULT; AGED; CAUSE OF DEATH; CICATRIX; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84864182823     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.070     Document Type: Article

References (59)

1. American Heart Association Heart Disease and Stroke Statistics - 2007 Update 2007 American Heart Association Dallas, TX
2. Centers for Medicaid and Medicare Services Decision Memo for Implantable Defibrillators (CAG-00157R3) 2007 Centers for Medicaid and Medicare Services Baltimore, MD
3. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
4. A. Kadish, A. Dyer, J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158 (Pubitemid 38637995)
5. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
6. R.J. Myerburg, R. Mitrani, A. Interian, A.L. Bassett, J. Simmons, A. Castellanos Life-threatening ventricular arrhythmias: the link between epidemiology and pathophysiology D. Zipes, J. Jalife, Cardiac Electrophysiology: From Cell to Bedside 2000 W.B. Saunders Company Philadelphia, PA 521 530
7. E.C. Stecker, C. Vickers, J. Waltz Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study J Am Coll Cardiol 47 2006 1161 1166
8. P.W. Groeneveld, M.A. Matta, J.J. Suh, P.A. Heidenreich, J.A. Shea Costs and quality-of-life effects of implantable cardioverter-defibrillators Am J Cardiol 98 2006 1409 1415 (Pubitemid 44666655)
9. R. Gradaus, M. Block, J. Brachmann Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID Pacing Clin Electrophysiol 26 2003 1511 1518 (Pubitemid 36836704)
10. D.A. Richards, G.J. Blake, J.F. Spear, E.N. Moore Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro Circulation 69 1984 369 381 (Pubitemid 14180342)
11. J.M. de Bakker, F.J. van Capelle, M.J. Janse Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation Circulation 77 1988 589 606 (Pubitemid 18073351)
12. K.P. Anderson, R. Walker, P. Urie, P.R. Ershler, R.L. Lux, S.V. Karwandee Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy J Clin Invest 92 1993 122 140 (Pubitemid 23208988)
13. K. Soejima, W.G. Stevenson, J.L. Sapp, A.P. Selwyn, G. Couper, L.M. Epstein Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842 (Pubitemid 38622524)
14. E. Wu, R.M. Judd, J.D. Vargas, F.J. Klocke, R.O. Bonow, R.J. Kim Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction Lancet 357 2001 21 28 (Pubitemid 32056497)
15. H. Mahrholdt, A. Wagner, M. Parker Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease J Am Coll Cardiol 42 2003 505 512 (Pubitemid 36951719)
16. D. Bello, D.J. Shah, G.M. Farah Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 2003 1945 1953 (Pubitemid 37296539)
17. J.A. McCrohon, J.C. Moon, S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59 (Pubitemid 36859020)
18. R.J. Kim, D.S. Fieno, T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002 (Pubitemid 29529292)
19. R.G. Assomull, S.K. Prasad, J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985 (Pubitemid 44738448)
20. L. Iles, H. Pfluger, L. Lefkovits Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
21. R.Y. Kwong, A.K. Chan, K.A. Brown Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743 (Pubitemid 43947991)
22. H.W. Kim, I. Klem, D.J. Shah Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease PLoS Medicine 6 2009 e1000057
23. E. Wu, J.T. Ortiz, P. Tejedor Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart (British Cardiac Society) 94 2008 730 736 (Pubitemid 351744690)
24. K.C. Wu, R.G. Weiss, D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421 (Pubitemid 351826874)
25. R.J. Gibbons, J. Abrams, K. Chatterjee ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) J Am Coll Cardiol 41 2003 159 168 (Pubitemid 36044419)
26. D.M. Bloomfield, J.T. Bigger, R.C. Steinman Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 47 2006 456 463 (Pubitemid 43063271)
27. S.G. Kim, R.N. Fogoros, S. Furman, S.J. Connolly, K.H. Kuck, A.J. Moss Standardized reporting of ICD patient outcome: the report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993 Pacing Clin Electrophysiol 16 1993 1358 1362 (Pubitemid 23209205)
28. M.S. Lauer, E.H. Blackstone, J.B. Young, E.J. Topol Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34 1999 618 620 (Pubitemid 29436163)
29. L.E. Hinkle Jr., H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464 (Pubitemid 12168347)
30. P. Marckmann, L. Skov, K. Rossen Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 2006 2359 2362 (Pubitemid 44300951)
31. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
32. F. Grothues, G.C. Smith, J.C. Moon Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34 (Pubitemid 34671198)
33. M.D. Cerqueira, N.J. Weissman, V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542 (Pubitemid 34262671)
34. D. Bello, D.S. Fieno, R.J. Kim Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 2005 1104 1108 (Pubitemid 40432446)
35. H. Mahrholdt, A. Wagner, R.M. Judd, U. Sechtem, R.J. Kim Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies Eur Heart J 26 2005 1461 1474 (Pubitemid 41373486)
36. A.T. Yan, A.J. Shayne, K.A. Brown Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality Circulation 114 2006 32 39 (Pubitemid 44305272)
37. J.P. Daubert, W. Zareba, W.J. Hall Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients J Am Coll Cardiol 47 2006 98 107 (Pubitemid 43005171)
38. M.J. Ricciardi, E. Wu, C.J. Davidson Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation Circulation 103 2001 2780 2783 (Pubitemid 32550063)
39. J.B. Selvanayagam, S.E. Petersen, J.M. Francis Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers Circulation 109 2004 345 350 (Pubitemid 38133902)
40. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12 (Pubitemid 351193639)
41. G. Gregoratos, J. Abrams, A.E. Epstein ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) J Am Coll Cardiol 40 2002 1703 1719 (Pubitemid 35253652)
42. W. Grimm, M. Christ, J. Bach, H.H. Muller, B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 2003 2883 2891 (Pubitemid 37517816)
43. J.J. Fenoglio Jr., T.D. Pham, A.H. Harken, L.N. Horowitz, M.E. Josephson, A.L. Wit Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates Circulation 68 1983 518 533 (Pubitemid 13050589)
44. L.N. Horowitz, A.H. Harken, J.A. Kastor, M.E. Josephson Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia N Engl J Med 302 1980 589 593 (Pubitemid 10073406)
45. W.C. Roberts, R.J. Siegel, B.M. McManus Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients Am J Cardiol 60 1987 1340 1355
46. F.M. Bogun, B. Desjardins, E. Good Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate J Am Coll Cardiol 53 2009 1138 1145
47. H.H. Hsia, D.J. Callans, F.E. Marchlinski Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia Circulation 108 2003 704 710 (Pubitemid 36999255)
48. S. Nazarian, D.A. Bluemke, A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825 (Pubitemid 41641676)
49. D.H. Kwon, C.M. Halley, T.P. Carrigan Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study J Am Coll Cardiol Img 2 2009 34 44
50. B.Y. Cheong, R. Muthupillai, J.M. Wilson Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction Circulation 120 2009 2069 2076
51. A.E. Buxton, K.L. Lee, G.E. Hafley Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial Circulation 106 2002 2466 2472 (Pubitemid 35278803)
52. O. Costantini, S.H. Hohnloser, M.M. Kirk The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention J Am Coll Cardiol 53 2009 471 479
53. E.S. Brilakis, P.A. Friedman, T.N. Maounis Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature Int J Cardiol 98 2005 395 401 (Pubitemid 40247927)
54. A.P. Gorgels, C. Gijsbers, J. de Vreede-Swagemakers, A. Lousberg, H.J. Wellens Out-of-hospital cardiac arrest - the relevance of heart failure The Maastricht Circulatory Arrest Registry Eur Heart J 24 2003 1204 1209 (Pubitemid 36834636)
55. J.J. Goldberger, M.E. Cain, S.H. Hohnloser American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention J Am Coll Cardiol 52 2008 1179 1199
56. R. Tung, P. Zimetbaum, M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
57. K.A. Ellenbogen, J.H. Levine, R.D. Berger Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
58. J.M. de Bakker, F.J. van Capelle, M.J. Janse Slow conduction in the infarcted human heart 'Zigzag' course of activation Circulation 88 1993 915 926 (Pubitemid 23264006)
59. B.A. Jones-Collins, R.E. Patterson Quantitative measurement of electrical instability as a function of myocardial infarct size in the dog Am J Cardiol 48 1981 858 863 (Pubitemid 12003535)